Insufficient scRNA-seq data for expression of C4A at single-cell level.
Insufficient scRNA-seq data for expression of C4A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 99% | 10171.12 | 224 / 226 | 95% | 76.49 | 386 / 406 |
thymus | 98% | 2594.92 | 642 / 653 | 86% | 29.05 | 523 / 605 |
kidney | 87% | 2134.49 | 77 / 89 | 81% | 33.51 | 727 / 901 |
breast | 84% | 921.09 | 386 / 459 | 76% | 37.74 | 853 / 1118 |
ovary | 97% | 2954.59 | 175 / 180 | 60% | 14.94 | 259 / 430 |
lung | 89% | 822.92 | 512 / 578 | 39% | 5.43 | 446 / 1155 |
prostate | 69% | 607.60 | 169 / 245 | 56% | 9.47 | 281 / 502 |
brain | 54% | 343.25 | 1414 / 2642 | 71% | 12.73 | 499 / 705 |
pancreas | 66% | 790.45 | 218 / 328 | 57% | 6.09 | 102 / 178 |
adrenal gland | 98% | 6430.21 | 254 / 258 | 17% | 3.16 | 38 / 230 |
intestine | 90% | 1169.45 | 870 / 966 | 15% | 2.05 | 78 / 527 |
uterus | 83% | 826.66 | 141 / 170 | 17% | 2.81 | 79 / 459 |
stomach | 66% | 511.07 | 238 / 359 | 30% | 4.09 | 87 / 286 |
spleen | 97% | 923.32 | 233 / 241 | 0% | 0 | 0 / 0 |
esophagus | 62% | 806.93 | 896 / 1445 | 34% | 5.97 | 62 / 183 |
bladder | 81% | 1130.05 | 17 / 21 | 12% | 1.43 | 61 / 504 |
blood vessel | 82% | 680.94 | 1089 / 1335 | 0% | 0 | 0 / 0 |
heart | 75% | 707.96 | 649 / 861 | 0% | 0 | 0 / 0 |
adipose | 66% | 783.31 | 797 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 23% | 2.74 | 18 / 80 |
skin | 6% | 23.04 | 116 / 1809 | 11% | 1.20 | 53 / 472 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.61 | 5 / 29 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.24 | 2 / 45 |
muscle | 4% | 16.85 | 34 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 1.94 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006954 | Biological process | inflammatory response |
GO_0006958 | Biological process | complement activation, classical pathway |
GO_0006956 | Biological process | complement activation |
GO_2000427 | Biological process | positive regulation of apoptotic cell clearance |
GO_0045087 | Biological process | innate immune response |
GO_0005615 | Cellular component | extracellular space |
GO_0072562 | Cellular component | blood microparticle |
GO_0030424 | Cellular component | axon |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0045202 | Cellular component | synapse |
GO_0005576 | Cellular component | extracellular region |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005886 | Cellular component | plasma membrane |
GO_0030425 | Cellular component | dendrite |
GO_0004866 | Molecular function | endopeptidase inhibitor activity |
GO_0001849 | Molecular function | complement component C1q complex binding |
Gene name | C4A |
Protein name | C4A2 (C4A3) (C4A4) (C4A6) (C4B1) Complement C4A (Rodgers blood group) Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain] Complement C4A3 Complement C4-A MHC class III region complement |
Synonyms | CPAMD2 CO4 |
Description | FUNCTION: Non-enzymatic component of C3 and C5 convertases and thus essential for the propagation of the classical complement pathway. Covalently binds to immunoglobulins and immune complexes and enhances the solubilization of immune aggregates and the clearance of IC through CR1 on erythrocytes. C4A isotype is responsible for effective binding to form amide bonds with immune aggregates or protein antigens, while C4B isotype catalyzes the transacylation of the thioester carbonyl group to form ester bonds with carbohydrate antigens.; FUNCTION: Derived from proteolytic degradation of complement C4, C4a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes. |
Accessions | A0A140TA32 A0A0G2JPR0 ENST00000549812.2 ENST00000698442.1 Q6U2K2 ENST00000375295.8 A0A8V8TLP6 Q30211 A0A140TA44 P0C0L4 ENST00000428956.7 [P0C0L4-1] V9H0D6 ENST00000546746.5 ENST00000550297.2 ENST00000421274.6 A0A140TA49 ENST00000498271.1 [P0C0L4-2] ENST00000383325.8 |